Chronic Hepatitis C
HEPATITIS C --- Navigation Topics
• Top New Articles on HCV
• All HCV Articles by Topic ( A to Z )
• HCV Basics
• HIV-HCV Coinfection
• FDA-approved Treatments for HCV
- Roferon A (interferon alfa-2a)
- Intron A (interferon alfa-2b)
- Infergen (consensus interferon)
- Pegasys (peginterferon alfa-2a)
- PegIntron (peginterferon alfa-2b)
- Copegus / Rebetol (ribavirin)
- Intron A + Rebetol
- Roferon A + Ribavirin
- Pegasys + Copegus
- PegIntron + Rebetol
• Treatment Guidelines for HCV
• Experimental Treatments for HCV
• Recent Research Conference Reports
• Tests for HCV
• Liver-related Complications
• Drug-related Adverse Events
• Doctor Is In 'Q and A' for HCV
• Library of CME Programs
• E-mail Update - Sign Up
• About Us - Contact Us
_______________
FibroTest / ActiTest / FibroScan
Battle of the New, Non-invasive Measures of Fibrosis:
FibroScan versus FibroTes
t
- 2/24/06
Fibroscan Is Superior to the
FibroTest
in the Noninvasive Identification of Fibrosis
- 9/28/05
Should Liver Biopsy Be Recommended Only as a Second Line Test in Chronic Hepatitis C Patients?
- 7/22/05
FibroTest
Is a Useful Screening Test for Significant Fibrosis in Hyperlipidemic Patients with Hepatitis B, Hepatitis C, and Alcoholic and Non Alcoholic Steatosis
- 5/11/05
Fibrosis Evaluation: Comparison of FibroScan with Liver Biopsy,
Fibrotest
, Fornscore, Apri, Hyaluronan, Prothrombin Time, and AST/ALT Ratio
- 5/02/05
Are Current Fibrosis Serum Markers an Adequate Alternative to Liver Biopsy?
- 5/02/05
Screening for Fibrosis with Non-invasive Biomarkers (
Fibrotest
) in Hyperlipidemic Patients
- 5/02/05
HIV AND AIDS
|
HEPATITIS B
|
HEPATITIS C
|
HIV / HBV CO-INFECTION
|
HIV / HCV CO-INFECTION
|
HEALTH AND TECHNOLOGY
|
TESTS
|
INTERNET CONFERENCE REPORTS
|
TELECONFERENCES
|
LINKS
|
ABOUT US
|
CONTACT US
